MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
OPKO Health Operating Cycle 2011-2025 | OPK
Annual Operating Cycle OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 285 | 298 | 111 | 56.1 | 53.5 | 97.9 | 85.2 | 93 | 103 | 217 | 219 | 254 | 474 | 446 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 474 | 53.5 | 199 |
Quarterly Operating Cycle OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112 | 114 | 55.7 | 96 | 105 | 83.9 | 57.1 | 47.8 | - | 31.3 | 31.3 | 65.5 | 58.5 | 61.6 | 60.5 | 50.8 | 52.8 | 61 | 86.7 | 90.8 | 54.8 | 53.7 | 54.3 | 57.1 | 59.2 | 52.6 | 49.8 | 55.4 | 93.8 | 61.4 | 51.6 | 66.1 | 81.4 | 67.4 | 56.3 | 64.9 | 64 | 124 | 668 | 573 | 71.4 | 228 | 198 | 209 | 87.2 | 225 | 202 | 216 | 119 | 435 | 499 | 501 | 198 | 471 | 385 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 668 | 31.3 | 144 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
275 | $ 20.75 | -2.01 % | $ 223 M |  China |
 |
Co-Diagnostics
CODX
|
405 | $ 0.23 | -3.91 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
97.9 | $ 39.22 | -0.44 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
150 | $ 230.27 | -0.02 % | $ 168 B | USA |
 |
DarioHealth Corp.
DRIO
|
251 | $ 10.22 | 1.79 % | $ 290 M |  Israel |
 |
BioNano Genomics
BNGO
|
329 | $ 1.52 | -0.16 % | $ 1.93 M | USA |
 |
Exact Sciences Corporation
EXAS
|
269 | $ 101.55 | -0.02 % | $ 18.8 B | USA |
 |
DexCom
DXCM
|
204 | $ 68.16 | 0.87 % | $ 26.3 B | USA |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 26.59 | -0.47 % | $ 804 M | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 19.3 | -0.92 % | $ 1.04 B | USA |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
385 | $ 3.17 | -1.09 % | $ 101 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 226.44 | -0.21 % | $ 41.1 B | USA |
 |
Guardant Health
GH
|
49.1 | $ 102.14 | -0.82 % | $ 12.5 B | USA |
 |
Myriad Genetics
MYGN
|
87.1 | $ 6.4 | -1.31 % | $ 580 M | USA |
 |
ENDRA Life Sciences
NDRA
|
412 | $ 4.66 | -8.27 % | $ 2.5 M | USA |
 |
Neogen Corporation
NEOG
|
213 | $ 7.27 | 1.89 % | $ 1.58 B | USA |
 |
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | USA |
 |
National Research Corporation
NRC
|
33 | $ 18.6 | -0.35 % | $ 456 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 27.32 | 0.77 % | $ 20 B |  Niderland |
 |
Personalis
PSNL
|
55.8 | $ 8.14 | - | $ 482 M | USA |
 |
Quidel Corporation
QDEL
|
68.4 | $ 29.39 | 0.31 % | $ 1.24 B | USA |
 |
QIAGEN N.V.
QGEN
|
172 | $ 45.94 | 1.26 % | $ 10.2 B | Niderland |
 |
Illumina
ILMN
|
198 | $ 134.51 | -0.33 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 202.78 | -0.43 % | $ 10.4 B | USA |
 |
RadNet
RDNT
|
34.9 | $ 72.71 | -0.6 % | $ 5.31 B | USA |
 |
Soleno Therapeutics
SLNO
|
193 | $ 47.59 | -0.13 % | $ 1.91 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
56.9 | $ 175.65 | -0.16 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 6.62 | -2.86 % | $ 858 M | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
72.9 | $ 253.7 | -0.07 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 181.2 | -0.9 % | $ 14.9 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
135 | $ 687.59 | -0.13 % | $ 56.7 B | USA |
 |
Lantheus Holdings
LNTH
|
116 | $ 67.17 | 0.69 % | $ 4.65 B | USA |